Cargando…

Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study

Detalles Bibliográficos
Autores principales:	Wästerlid, Tove, Hasselblom, Sverker, Joelsson, Joel, Weibull, Caroline E., Rassidakis, Georgios, Sander, Birgitta, Smedby, Karin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139945/ https://www.ncbi.nlm.nih.gov/pubmed/34021121 http://dx.doi.org/10.1038/s41408-021-00491-7

Ejemplares similares

Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study
por: Joelsson, Joel, et al.
Publicado: (2022)

Sex differences in lymphoma incidence and mortality by subtype: A population‐based study
por: Radkiewicz, Cecilia, et al.
Publicado: (2022)

Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden
por: Weibull, Caroline E., et al.
Publicado: (2023)

Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study
por: Wästerlid, Tove, et al.
Publicado: (2020)

Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study
por: Haider, Zahra, et al.
Publicado: (2023)

Excellent survival after R‐Hyper‐CVAD in hospitalized patients with high‐risk large B‐cell lymphoma: The Karolinska experience
por: Sonnevi, Kristina, et al.
Publicado: (2021)

Thinking Outside the Box in Mediastinal Lymphoma Management
por: Alhamss, Marwa, et al.
Publicado: (2023)

Data-driven support to decision-making in molecular tumour boards for lymphoma: A design science approach
por: Rodríguez Ruiz, Núria, et al.
Publicado: (2022)

Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017
por: Albertsson-Lindblad, Alexandra, et al.
Publicado: (2021)

Age is the most important predictor of survival in diffuse large B‐cell lymphoma patients achieving event‐free survival at 24 months: a Swedish population‐based study
por: Abu Sabaa, Amal, et al.
Publicado: (2021)

Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
por: Ekberg, Sara, et al.
Publicado: (2022)

SILAC-Based Quantitative Proteomic Analysis of Diffuse Large B-Cell Lymphoma Patients
por: Rüetschi, Ulla, et al.
Publicado: (2015)

External review and validation of the Swedish national inpatient register
por: Ludvigsson, Jonas F, et al.
Publicado: (2011)

PD-L1(+) macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma
por: Steiner, Raphael E., et al.
Publicado: (2023)

Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project
por: Jerkeman, Mats, et al.
Publicado: (2023)

The Swedish Fracture Register – ten years of experience and 600,000 fractures collected in a National Quality Register
por: Möller, Michael, et al.
Publicado: (2022)

Pediatric mediastinal lymphoma
por: Mallick, Saumyaranjan, et al.
Publicado: (2020)

ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells
por: Ghaderi, Amineh, et al.
Publicado: (2020)

Mediastinal tumor: not always a lymphoma
por: Reimão, Silvia Mansur, et al.
Publicado: (2017)

P081: Treatment-related circulatory diseases and mortality in Hodgkin lymphoma patients using multi-state modelling and relative survival
por: Baech, Joachim, et al.
Publicado: (2022)

Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma
por: Merrien, Magali, et al.
Publicado: (2021)

Burkitt's lymphoma of the mandible
por: Kuo, Ying-Shiung, et al.
Publicado: (2017)

Application of precision medicine in clinical routine in haematology—Challenges and opportunities
por: Wästerlid, Tove, et al.
Publicado: (2022)

Concomitant occurrence of genetically distinct Hodgkin lymphoma and primary mediastinal lymphoma
por: Dubois, Sydney, et al.
Publicado: (2021)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
por: Biasoli, Irene, et al.
Publicado: (2023)

Heart of Lymphoma: Primary Mediastinal Large B-Cell Lymphoma with Endomyocardial Involvement
por: Rogowitz, Elisa, et al.
Publicado: (2013)

Risk of malignant lymphoma in Swedish pesticide appliers.
por: Wiklund, K., et al.
Publicado: (1987)

Mediastinal large-cell lymphoma with sclerosis (MLCLS).
por: Rohatiner, A. Z., et al.
Publicado: (1994)

Mediastinal Choriocarcinoma Masquerading as Relapsed Hodgkin Lymphoma
por: Lam, Selay, et al.
Publicado: (2011)

Mediastinal cryptococcosis masquerading as therapy-refractory lymphoma
por: Wong, Matthew, et al.
Publicado: (2010)

Primary Mediastinal Large B-cell Lymphoma
por: Dabrowska-Iwanicka, Anna, et al.
Publicado: (2014)

Targeting primary mediastinal B-cell lymphoma
por: Wagner, Simon D.
Publicado: (2014)

Primary mediastinal large B cell lymphoma
por: Yu, Yating, et al.
Publicado: (2021)

Primary mediastinal large B‐cell lymphoma
por: Villa, Diego, et al.
Publicado: (2020)

KIT mutations in primary mediastinal B-cell lymphoma
por: Nagel, P D, et al.
Publicado: (2014)

T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway
por: Entrop, Joshua P., et al.
Publicado: (2022)

Occupational Benzene Exposure and Lymphoma Risks
por: Sorahan, Tom
Publicado: (2011)

Intracerebral manifestation of iatrogenic, immunodeficiency-associated polymorphic B-LPD with morphology mimicking Hodgkin lymphoma: a case report and literature review
por: Saft, Leonie, et al.
Publicado: (2022)

Characteristics of human primary mantle cell lymphoma engraftment in NSG mice
por: Iyengar, Sunil, et al.
Publicado: (2015)

The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells
por: Abeykoon, Jithma P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_69s880lnduaplokckiq6m5os2m